TAT and HIV infectious disease: These data provide preliminary evidence that the weak anti-Tat antibody responses elicited during early or chronic HIV infection had minimal inhibitory activity, but high-level anti-Tat responses with potent neutralizing activity and distinct peptide specificity, could be elicited by vaccination.